2 completed, 1 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow TER 286: new trials by email Literature Review of TER 286 trials Research Report on TER 286
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer Telcyta, Liposomal Doxorubicin - Ovarian Neoplasms | Phase 3 | Terminated | Telik | 244 | 2006-05-01 | 2013-11-27 |
| TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer TLK286 in Combination with Carboplatin, Doxorubicin HCl Liposome Injection - Ovarian Neoplasms | Phase 3 | Completed | Telik | 244 | 2004-12-01 | 2012-05-31 |
| Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer TLK286 (Telcyta) HCl for Injection, gefitinib (Iressa) - Non Small Cell Lung Carcinoma | Phase 3 | Completed | Telik | 520 | 2008-01-15 |
Ovarian Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1)
Telik (3)
United States (3) · Brazil (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Belgium (1) · Chile (1) · Germany (1) · Italy (1)